The inspirational, international, and visionary forum dedicated to Pharma, MedTech, Healthcare and Life Sciences.
Where inspiration, learning and high-level networking come together.
from the pharma & healthcare industries
Executives, Managers, Directors
WOMA is for those who want to leave a mark on the world.
Its audience includes current and future leaders from across the pharma, medtech, healthcare, and life sciences ecosystems.
The people WOMA inspires are the ones who make change happen.
Be part of WOMA, contribute to the change.
WOMA is a unique place where ideas and visions converge, generating authentic connections and unexpected inspiration. An experience distinguished by the unique quality of its inspirational, visionary, and educational content, specifically tailored for the Pharma, MedTech, Healthcare, and Life Sciences sectors.
Nobel Prize winners, global leaders, influential and provocative CEOs: world-renowned speakers, independent and visionary, with the proven ability to disrupt established narratives.
CRISPR co-inventor and Nobel Prize-winning biochemist at the University of California, Berkeley
The Medical Futurist
Social Psychologist • Author • TED Speaker
Futurist and Former Head of GTM at Open AI
Former President of the European Commission, Former Prime Minister of Portugal
Co-founder and Chief Scientific Officer Rubedo Life Sciences
Sales Director for MFS International Ltd.
Global Business Lead Pharma & Life Sciences, Microsoft
Ecosystem | Innovation | Digital | Science | AI | Leadership | People | Strategy | Health Economy | Purpose
18:00 – 22:00
18:00
Registration and Networking Welcome
18:45
Opening Ceremony
19:00
Opening Istitutional Panel
19:30
New Health Economy
José Manuel Durão Barroso
20:30
Charity Dinner in aid of AIRC
9:00 – 17:00
09:20
Future of Technologies in Medicine
Dr. Bertalan Meskó, MD, PhD
Networking Coffee Break
11:10
The next RenAIssance: driving transformation with AI
Zack Kass
12:20
Inspiration in Science by Nobel Prize
Dr. Jennifer Doudna, PhD
Networking Lunch
15:00
Vision & Strategy
Marco Quarta, Assunta Siviero
15:40
Leadership & People
Dr. Amy Cuddy
Networking Closing Drinks
New Health Economy
José Manuel Durão Barroso
Future of Technologies in Medicine
Dr. Bertalan Meskó, MD, PhD
The next RenAIssance: driving transformation with AI
Zack Kass
Inspiration in Science by Nobel Prize
Dr. Jennifer Doudna, PhD
Vision & Strategy
Marco Quarta
Assunta Siviero
Antonio Gatti
Leadership & People
Dr. Amy Cuddy
Don’t miss your chance to be part of it: secure your spot at the event for an experience that is sure to leave a lasting impression.
Access to on-demand content.
€690 + VAT
What’s Included
The complete experience: content, networking, and physical access to the event.
€1570 + VAT
What’s Included
The exclusive experience for top executives and C-Level.
€2800 + VAT
Sold Out
What’s Included
We build ticket packages for your team, offering an exclusive, engaging, and strategically winning experience.
We build ticket packages for your team, offering an exclusive, engaging, and strategically winning experience.
The Allianz MiCo Milano Congressi is the largest conference center in Europe, now with a completely new and versatile layout.
Easily accessible from all parts of the city—including Milan’s three airports—and well connected to the public transport network. Sustainability is a key value, with LEED V4 O+M, ISO 20121:2013, and ISO 14001:2015 certifications. WOMA will be held in the new North Wing, Level +2, with access from Gate 5 (Viale Teodorico).
WOMA is shaping the future of pharma, medtech, healthcare, and life sciences. It celebrates courage, innovation, and the next big step. Being a partner is an opportunity to leave a mark that will inspire the community for years to come.
Contact the WOMA team to define the sponsorship formula best suited to your company.
An event conceived and organized by
Organizing Secretariat | Event Partner
Promoted by
Media Partner
Main Partner
Gold Sponsor
Sponsors
Sponsors
Patronage
Institutional Partner
Charity Partner
Academic Partner
Association Partner
Ecosystem Media partner
Digital communication partner
Partner for institutional relations
Life Sciences Media Partner
Media Supporter
Official Bookstore
Ecosystem Partner
Technical Partner
Tickets purchased will not be refunded. If you are unable to attend, you may request to reuse your ticket for the following edition, provided you notify WOMA at info@womaforum.com at least 72 hours before the event. Failure to participate without prior notice will not entitle you to a refund or reuse.
Tickets are personal and cannot be assigned or transferred for commercial or promotional purposes. Name changes are permitted up to 10 business days before the event, via info@womaforum.com. For corporate packages, tickets can only be assigned to company employees, unless WOMA has written authorization.
During checkout, you can enter your company information (name, VAT number, address) for invoicing purposes. The invoice will be generated automatically.
WOMA 2026 takes place on June 25th from 6:00 PM to 10:00 PM; June 26th from 9:00 AM to 6:00 PM
The event offers multiple networking opportunities including:
WOMA 2026 will be held at Allianz MiCo – Gate 5 , Viale Teodorico, 20149 Milan MI, Italy
Yes. You can purchase multiple tickets in the same order directly from the website or request a customized package for corporate teams at info@womaforum.com.
Of course, here you can find the list of partner hotels.
Early Bird rates are available for a limited time. Secure your spot at WOMA Forum 2026.
Jennifer Doudna, PhD, is a biochemist at the University of California, Berkeley. Her groundbreaking development of CRISPR-Cas9 — a genome engineering technology that allows researchers to edit DNA — with collaborator Emmanuelle Charpentier earned the pair the 2020 Nobel Prize in Chemistry and forever changed the course of human and agricultural genomic research. She is also the founder of the Innovative Genomics Institute, the Li Ka Shing Chancellor’s Chair in Biomedical and Health Sciences, and a member of the Howard Hughes Medical Institute, Lawrence Berkeley National Lab, Gladstone Institutes, National Academy of Sciences, and American Academy of Arts and Sciences. She is a leader in the global public debate on the responsible use of CRISPR and has co-founded and serves on the advisory board of several companies using the technology in unique ways. Doudna is co-author of “A Crack in Creation”, a personal account of her research and the social and ethical implications of gene editing. To learn more, visit innovativegenomics.org/jennifer-doudna
Dr. Bertalan Mesko, PhD, known as The Medical Futurist, is the Director of The Medical Futurist Institute. He specializes in analyzing the impact of science fiction technologies on global medicine and healthcare.
A physician passionate about technology with a PhD in genomics, he is also an Amazon Top 100 author and a private professor at Semmelweis Medical School in Budapest, Hungary.
Dr. Mesko has delivered over 900 keynotes at prestigious institutions such as Harvard, Stanford, and Yale universities, as well as organizations like WHO and the world’s top 10 pharmaceutical companies. His insights into healthcare technology have made him a leading global voice in the industry.
Featured in major media outlets including CNN, National Geographic, Forbes, TIME magazine, BBC, and The New York Times, Dr. Mesko regularly shares his analyses on medicalfuturist.com.
His research focuses on the role of “artificial intelligence and digital health technologies in shaping the future of” healthcare. He is a member of the “Committee on Future Research” at the Hungarian Academy of Sciences.
Dedicated to pioneering studies on the futures of medicine as a scientific discipline, Dr. Mesko aims to make forecasting methods widely accessible in healthcare.
He is a Certified Superforecaster for Good Judgment, Inc.
Amy Cuddy is a social psychologist and New York Times bestselling author who has taught at Harvard Business School and Kellogg School of Management, and has been awarded Harvard’s Excellence in Teaching Award. She earned her Ph.D. from Princeton University and is an expert in the behavioral science of personal power, nonverbal behavior, trust-based leadership, and effective management of people and biases in high-pressure environments. Her book Presence has been translated into 35 languages and has sold over 600,000 copies, while her TED Talk, one of the most viewed in the world with over 74 million views, has influenced an entire generation on the topics of self-confidence and nonverbal communication. Her new book, Bullied (HarperCollins, 2026), redefines bullying among adults as an urgent crisis with devastating personal, organizational, and social costs, and provides readers with the tools to recognize, name, and stop it. Named by Thinkers50 as one of the 50 most influential management thinkers in the world and recognized as a Young Global Leader by the World Economic Forum, Dr. Cuddy is internationally known for her research and public engagement on leadership, empowerment, and organizational well-being. Her ideas have appeared in major media including BBC, TIME, Harvard Business Review, The Guardian and The New York Times. Her work inspires companies, leaders, and teams to cultivate more mindful, inclusive, empowering, and successful environments.
Zack Kass is a global AI advisor, researcher, keynote speaker, and former Head of Go-To-Market at OpenAI, where he led global sales, partnerships, and customer success. He now advises Fortune 1000 companies like Coca-Cola, Morgan Stanley, and Amgen on AI adoption, helping leaders turn innovation into strategy. His mission is to make AI understandable and actionable, ensuring businesses, governments, and individuals shape its future responsibly. Featured in major outlets such as Fortune and Business Insider, he also supports education and research at the University of Virginia. A UC Berkeley graduate, Zack is recognized as a leading voice in applied AI and is based in Santa Barbara, California.
José Manuel Durão Barroso is a leading global figure.
He was President of the European Commission from 2004 to 2014 and Prime Minister of Portugal from 2002 to 2004.
In 1999, Barroso was elected president of the Portuguese Social Democratic Party and became leader of the opposition.
In 2002 he was elected Prime Minister of Portugal and in 2004 he was appointed President of the European Commission.
Barroso served two five-year terms as President, during which he played an influential role in the ratification of the Lisbon Treaty, the response to the financial crisis, and the accession of new members to the European Union, as the EU grew from 15 to 28 countries between 2004 and 2014. On behalf of the EU, José Manuel Barroso received the Nobel Peace Prize in 2012 and delivered the acceptance speech together with the President of the European Council.
Since 2016, he has been non-executive chairman of Goldman Sachs International and an advisor to Goldman Sachs, and since 2021, José Manuel Barroso has been chairman of the board of Gavi, the Vaccine Alliance.
Gavi is a global public-private health partnership aimed at increasing access to immunization in low-income countries, supporting the vaccination of nearly half of the world’s children.
Barroso’s academic positions include visiting professor at Georgetown University and, most recently, visiting professor of International Economic Policy and fellow at the Woodrow Wilson School at Princeton.
University.
Dr. Marco Quarta is a scientist, entrepreneur, and leading biotechnology executive specializing in the biology of aging and regenerative medicine. He is the founding CEO and current Chief Scientific Officer of Rubedo Life Sciences, a pioneering company in the field of therapies for age-related diseases. Previously, he directed translational research programs at Stanford University School of Medicine and the VA Palo Alto Hospital. A member of the Board of Directors of the European Biotechnology Federation and author of “Sfidare il Tempo,” he has co-founded several biotechnology companies and holds over 60 scientific publications and patents.
Antonio Gatti leads Global Pharma & Life Sciences at Microsoft and serves as Worldwide GTM Lead for Microsoft Discovery, the enterprise agentic platform for accelerating scientific discovery, which he helped incubate from within. His work focuses on how agentic AI is reshaping the R&D and drug discovery process across the world’s largest pharma and biotech organizations: from scientific knowledge reasoning and hypothesis generation through candidate screening, simulation, and analysis and on the enterprise patterns that make these capabilities trustworthy and deployable in regulated environments.
He brings nearly two decades bridging technology and business transformation: a decade at Accenture’s Technology Strategy practice advising C-suites, followed by a decade at Microsoft, where
he founded the digital advisory practice. He is also co-founder and faculty lead of the AI-Driven Business Models Executive Master at Università Cattolica del Sacro Cuore di Milano. He holds an Executive MBA from the POLIMI Graduate School of Management, and executive education from INSEAD.
Jennifer Doudna, PhD, is a biochemist at the University of California, Berkeley. Her groundbreaking development of CRISPR-Cas9 — a genome engineering technology that allows researchers to edit DNA — with collaborator Emmanuelle Charpentier earned the pair the 2020 Nobel Prize in Chemistry and forever changed the course of human and agricultural genomic research. She is also the founder of the Innovative Genomics Institute, the Li Ka Shing Chancellor’s Chair in Biomedical and Health Sciences, and a member of the Howard Hughes Medical Institute, Lawrence Berkeley National Lab, Gladstone Institutes, National Academy of Sciences, and American Academy of Arts and Sciences. She is a leader in the global public debate on the responsible use of CRISPR and has co-founded and serves on the advisory board of several companies using the technology in unique ways. Doudna is co-author of “A Crack in Creation”, a personal account of her research and the social and ethical implications of gene editing. To learn more, visit innovativegenomics.org/jennifer-doudna
Dr. Bertalan Mesko, PhD, known as The Medical Futurist, is the Director of The Medical Futurist Institute. He specializes in analyzing the impact of science fiction technologies on global medicine and healthcare.
A physician passionate about technology with a PhD in genomics, he is also an Amazon Top 100 author and a private professor at Semmelweis Medical School in Budapest, Hungary.
Dr. Mesko has delivered over 900 keynotes at prestigious institutions such as Harvard, Stanford, and Yale universities, as well as organizations like WHO and the world’s top 10 pharmaceutical companies. His insights into healthcare technology have made him a leading global voice in the industry.
Featured in major media outlets including CNN, National Geographic, Forbes, TIME magazine, BBC, and The New York Times, Dr. Mesko regularly shares his analyses on medicalfuturist.com.
His research focuses on the role of “artificial intelligence and digital health technologies in shaping the future of” healthcare. He is a member of the “Committee on Future Research” at the Hungarian Academy of Sciences.
Dedicated to pioneering studies on the futures of medicine as a scientific discipline, Dr. Mesko aims to make forecasting methods widely accessible in healthcare.
He is a Certified Superforecaster for Good Judgment, Inc.
Amy Cuddy is a social psychologist and New York Times bestselling author who has taught at Harvard Business School and Kellogg School of Management, and has been awarded Harvard’s Excellence in Teaching Award. She earned her Ph.D. from Princeton University and is an expert in the behavioral science of personal power, nonverbal behavior, trust-based leadership, and effective management of people and biases in high-pressure environments. Her book Presence has been translated into 35 languages and has sold over 600,000 copies, while her TED Talk, one of the most viewed in the world with over 74 million views, has influenced an entire generation on the topics of self-confidence and nonverbal communication. Her new book, Bullied (HarperCollins, 2026), redefines bullying among adults as an urgent crisis with devastating personal, organizational, and social costs, and provides readers with the tools to recognize, name, and stop it. Named by Thinkers50 as one of the 50 most influential management thinkers in the world and recognized as a Young Global Leader by the World Economic Forum, Dr. Cuddy is internationally known for her research and public engagement on leadership, empowerment, and organizational well-being. Her ideas have appeared in major media including BBC, TIME, Harvard Business Review, The Guardian and The New York Times. Her work inspires companies, leaders, and teams to cultivate more mindful, inclusive, empowering, and successful environments.
Zack Kass is a global AI advisor, researcher, keynote speaker, and former Head of Go-To-Market at OpenAI, where he led global sales, partnerships, and customer success. He now advises Fortune 1000 companies like Coca-Cola, Morgan Stanley, and Amgen on AI adoption, helping leaders turn innovation into strategy. His mission is to make AI understandable and actionable, ensuring businesses, governments, and individuals shape its future responsibly. Featured in major outlets such as Fortune and Business Insider, he also supports education and research at the University of Virginia. A UC Berkeley graduate, Zack is recognized as a leading voice in applied AI and is based in Santa Barbara, California.
José Manuel Durão Barroso is a leading global figure.
He was President of the European Commission from 2004 to 2014 and Prime Minister of Portugal from 2002 to 2004.
In 1999, Barroso was elected president of the Portuguese Social Democratic Party and became leader of the opposition.
In 2002 he was elected Prime Minister of Portugal and in 2004 he was appointed President of the European Commission.
Barroso served two five-year terms as President, during which he played an influential role in the ratification of the Lisbon Treaty, the response to the financial crisis, and the accession of new members to the European Union, as the EU grew from 15 to 28 countries between 2004 and 2014. On behalf of the EU, José Manuel Barroso received the Nobel Peace Prize in 2012 and delivered the acceptance speech together with the President of the European Council.
Since 2016, he has been non-executive chairman of Goldman Sachs International and an advisor to Goldman Sachs, and since 2021, José Manuel Barroso has been chairman of the board of Gavi, the Vaccine Alliance.
Gavi is a global public-private health partnership aimed at increasing access to immunization in low-income countries, supporting the vaccination of nearly half of the world’s children.
Barroso’s academic positions include visiting professor at Georgetown University and, most recently, visiting professor of International Economic Policy and fellow at the Woodrow Wilson School at Princeton.
University.
Dr. Marco Quarta is a scientist, entrepreneur, and leading biotechnology executive specializing in the biology of aging and regenerative medicine. He is the founding CEO and current Chief Scientific Officer of Rubedo Life Sciences, a pioneering company in the field of therapies for age-related diseases. Previously, he directed translational research programs at Stanford University School of Medicine and the VA Palo Alto Hospital. A member of the Board of Directors of the European Biotechnology Federation and author of “Sfidare il Tempo,” he has co-founded several biotechnology companies and holds over 60 scientific publications and patents.
Antonio Gatti leads Global Pharma & Life Sciences at Microsoft and serves as Worldwide GTM Lead for Microsoft Discovery, the enterprise agentic platform for accelerating scientific discovery, which he helped incubate from within. His work focuses on how agentic AI is reshaping the R&D and drug discovery process across the world’s largest pharma and biotech organizations: from scientific knowledge reasoning and hypothesis generation through candidate screening, simulation, and analysis and on the enterprise patterns that make these capabilities trustworthy and deployable in regulated environments.
He brings nearly two decades bridging technology and business transformation: a decade at Accenture’s Technology Strategy practice advising C-suites, followed by a decade at Microsoft, where
he founded the digital advisory practice. He is also co-founder and faculty lead of the AI-Driven Business Models Executive Master at Università Cattolica del Sacro Cuore di Milano. He holds an Executive MBA from the POLIMI Graduate School of Management, and executive education from INSEAD.
